Biblio
Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy. Oncotarget. 2016.
Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480. PLoS One. 2016;11(7):e0158903.
The future of immunotherapy for sarcoma. Expert Opin Biol Ther. 2016.
Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance. Oncoimmunology. 2016;5(6):e1165376.